5 Things to Know if You Missed CICON24

CICON24 wrapped up on September 11, 2024, at the Gaylord National Resort and Convention Center in National Harbor, MD, showcasing breakthrough advancements that are set to transform cancer treatment. From CAR-T cell innovations to the microbiome’s role in immunotherapy, the conference spotlighted the next frontier in cancer care and there was truly something for anyone with an interest in cancer immunology.

Here are five key takeaways from CICON24:

---

1 – CRI Ushers in a New Era of Transformative Leadership 

A significant milestone at CICON24 was the announcement of a new era of leadership at the Cancer Research Institute (CRI). The conference opened Monday, September 9, with Dr. Jill O’Donnell-Tormey introducing attendees to CRI’s new Chief Executive Officer. Dr. Alicia Zhou was appointed as the new CEO, effective August 26, 2024, succeeding Dr. O’Donnell-Tormey, who led CRI for over three decades. Dr. Zhou brings a wealth of experience in both academia and industry, with a strong focus on advancing equitable cancer care and treatment. Her leadership promises to steer CRI into a new era of innovation, particularly in personalized medicine, advanced vaccines, and cell therapies, reinforcing CRI’s commitment to expanding the reach of immunotherapy for all cancer patients.

---

2 – A Glimpse at the Future of Cancer Immunotherapy

CICON24 offered a glimpse into the future of cancer immunotherapy, exploring how the immune system can fight cancer. Sessions covered neoadjuvant trials, multiomic data analysis, and the role of inflammation, immune health, and myeloid cells in cancer treatment. Attendees also learned about the links between diet, the microbiome, and cancer, as well as the promise of personalized vaccines and cellular therapies. Keynotes from Dr. Cathy Wu and Dr. Diane J. Mathis highlighted cutting-edge breakthroughs, all reinforcing CICON24’s theme of translating science into survival.

---

3 – Colleague Connections and Innovative Invitations 

---

4 – Young Scientists Showcasing Their Research During Proffered Talks  

Meanwhile, Dr. Chiara Falcomata of Mount Sinai captivated the audience with her research on pancreatic tumor microenvironments, revealing how tumors adapt and offering new strategies for modulating immune responses. These talks exemplify the innovations shaping the future of cancer treatment.

---

5 – Trading Lab Coats for Ball Caps 

Take them out to the ballgame! Amidst the groundbreaking science and new discoveries being discussed, CICON24 attendees also found time for fun and relaxation. On Tuesday, September 10th, over 100 researchers and scientists took a break to enjoy a baseball game between the Washington Nationals and the Atlanta Braves. Organized by the CICON24 committee, the outing provided a much-needed opportunity to unwind and recharge before the final sessions of the conference. 

---

Conclusion 

CICON24 underscored the rapid advances in cancer immunotherapy and the critical role of collaboration in driving this field forward. From deep scientific insights to career-building advice, the conference offered an inspiring view of how innovation and passion will continue to shape the future of cancer treatment. With new leadership at CRI and a vibrant scientific community pushing boundaries, the future of immunotherapy looks brighter than ever.